Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (33)

« Back to Publications

SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management.

Nguyen D. et al, (2025), Journal of virology, 99

Characterising the molecular epidemiology of human parechovirus in young infants in the UK and Canada

Kadambari S. et al, (2024), Journal of Clinical Virology, 174, 105715 - 105715

Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma.

Nguyen D. et al, (2022), The Journal of infectious diseases, 225, 971 - 976

Highly-Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe Polymerase Chain Reaction

Ratcliff J. et al, (2021)

Variable short duration treatment versus standard treatment, with and without adjunctive ribavirin, for chronic hepatitis C: the STOP-HCV-1 non-inferiority, factorial RCT

Cooke GS. et al, (2021), Efficacy and Mechanism Evaluation, 8, 1 - 90

Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction.

Lamikanra A. et al, (2021), Transfusion, 61, 2837 - 2843

Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017

Kamau E. et al, (2021), Emerging Infectious Diseases, 27, 2261 - 2268

No Exchange of Picornaviruses in Vietnam between Humans and Animals in a High-Risk Cohort with Close Contact despite High Prevalence and Diversity

Lu L. et al, (2021), Viruses, 13, 1709 - 1709

Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection

Ratcliff J. et al, (2021), The Journal of Infectious Diseases, 224, 595 - 605

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Cooke GS. et al, (2021), Wellcome Open Research, 6, 93 - 93

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Cooke GS. et al, (2021)

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data.

Nguyen D. et al, (2021), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 26

A Novel Immunofluorescence Assay for the Rapid Serological Detection of SARS-CoV-2 Infection

Nguyen D. et al, (2021), Viruses, 13, 747 - 747

Virological and serological characterization of critically ill patients with COVID-19 in the UK: a special focus on variant detection

Ratcliff J. et al, (2021)

Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Cooke GS. et al, (2021)

Load More